Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients
Clinical trial NCT06364072 · COMPLETED
Trial details
- NCT number
- NCT06364072
- Sponsor
- Cessatech A/S
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-27
- Primary completion
- 2025-05-09
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.